The CEO of Pfizer Albert Bourla said on Thursday that coronavirus vaccine recipients will “likely” need a third dose between six and 12 months after their second dose.
Pfizer and Bio-Ntech said earlier this month that their vaccine was 91 percent effective for a minimum of six months after the second dose.
Speaking with CNBC’s Bertha Coombs at a CVS Health event on Thursday, Bourla suggested that vaccinations for coronavirus could be needed every year.
Bourla described the yearly vaccination against the coronavirus as a “likely scenario.”
“A likely scenario is there will be likely a need for a third dose somewhere between six and 12 months and from there there would be an annual revaccination,” Bourla said at the event. “But all of that needs to be confirmed and again the variants will play a key role.”
He said “it is extremely important to suppress the pool of people that can be susceptible to the virus because they are vaccinated with high-efficacy vaccine.”